Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDXeris Biopharma Holdings Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.08 | $0.04 | -$0.00 |
| Q2 2026 | 3 | $0.01 | $0.03 | $0.02 |
| Q3 2026 | 1 | $0.04 | $0.04 | $0.04 |
| Q4 2026 | 1 | $0.06 | $0.06 | $0.06 |
| Q1 2027 | 1 | $0.03 | $0.04 | $0.04 |
| Q2 2027 | 1 | $0.07 | $0.07 | $0.07 |
| Q3 2027 | 1 | $0.10 | $0.10 | $0.10 |
| Q4 2027 | 1 | $0.13 | $0.14 | $0.14 |
| Q1 2028 | 1 | $0.07 | $0.07 | $0.07 |
| Q2 2028 | 1 | $0.09 | $0.09 | $0.09 |
| Q3 2028 | 1 | $0.12 | $0.12 | $0.12 |
| Q4 2028 | 1 | $0.13 | $0.13 | $0.13 |
Xeris Biopharma Holdings Inc Earnings Date And Information
Xeris Biopharma Holdings Inc last posted its earnings results on Monday, March 2nd, 2026. The company reported $0.06 earnings per share for the quarter, topping analysts' consensus estimates of $0.03 by $0.03. The company had revenue of 85.81 M for the quarter and had revenue of 291.85 M for the year. Xeris Biopharma Holdings Inc has generated $0 earnings per share over the last year ($0.0032 diluted earnings per share) and currently has a price-to-earnings ratio of 1927.73. Xeris Biopharma Holdings Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Xeris Biopharma Holdings Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/02/2026 | Q4 2025 | $0.03 | $0.07 | 0.04 | $82.20 M | $85.81 M |
| 11/06/2025 | Q3 2025 | $0.01 | $0.00 | -0.01 | $74.19 M | $74.38 M |
| 08/07/2025 | Q2 2025 | -$0.03 | -$0.01 | 0.02 | $64.44 M | $71.54 M |
| 05/08/2025 | Q1 2025 | -$0.07 | -$0.06 | 0.01 | $57.62 M | $60.12 M |
| 03/06/2025 | Q4 2024 | -$0.08 | -$0.03 | 0.05 | $58.10 M | $60.10 M |
| 11/08/2024 | Q3 2024 | -$0.09 | -$0.11 | -0.02 | $51.45 M | $54.27 M |
| 08/08/2024 | Q2 2024 | -$0.11 | -$0.10 | 0.01 | $45.84 M | $48.07 M |
| 05/09/2024 | Q1 2024 | -$0.12 | -$0.14 | -0.02 | $41.81 M | $40.64 M |
| 03/06/2024 | Q4 2023 | -$0.09 | -$0.10 | -0.01 | N/A | $44.39 M |
| 11/09/2023 | Q3 2023 | -$0.12 | -$0.09 | 0.03 | N/A | $48.32 M |
| 08/08/2023 | Q2 2023 | -$0.13 | -$0.14 | -0.01 | N/A | $38.01 M |
| 05/09/2023 | Q1 2023 | -$0.17 | -$0.12 | 0.05 | N/A | $33.20 M |
| 03/08/2023 | Q4 2022 | -$0.16 | -$0.10 | 0.06 | N/A | $33.14 M |
| 11/09/2022 | Q3 2022 | -$0.17 | -$0.16 | 0.01 | N/A | $29.73 M |
| 08/10/2022 | Q2 2022 | -$0.23 | -$0.19 | 0.04 | N/A | $25.31 M |
| 05/11/2022 | Q1 2022 | -$0.24 | -$0.25 | -0.01 | N/A | $22.07 M |
| 03/11/2022 | Q4 2021 | N/A | -$0.42 | N/A | N/A | $21.67 M |
| 11/10/2021 | Q3 2021 | -$0.37 | -$0.39 | -0.02 | N/A | $11.04 M |
| 08/05/2021 | Q2 2021 | -$0.31 | -$0.41 | -0.1 | N/A | $8.91 M |
| 05/13/2021 | Q1 2021 | -$0.31 | -$0.30 | 0.01 | N/A | $8.20 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Xeris Biopharma Holdings Inc Earnings: FAQ's
In the previous quarter, Xeris Biopharma Holdings Inc (:XERS) reported $0.06 earnings per share (EPS) to beat the analysts' consensus estimate of $0.03 by $0.03.
The conference call for Xeris Biopharma Holdings Inc's latest earnings report can be listened to online.
The conference call transcript for Xeris Biopharma Holdings Inc's latest earnings report can be read online.
Xeris Biopharma Holdings Inc (:XERS) has a recorded annual revenue of $291.85 M.
Xeris Biopharma Holdings Inc (:XERS) has a recorded net income of $554.00 K.Xeris Biopharma Holdings Inc has generated $0.0035 earnings per share over the last four quarters.
Xeris Biopharma Holdings Inc (:XERS) has a price-to-earnings ratio of 1927.73 and price/earnings-to-growth ratio is 5.25.